Innovate Biopharmaceuticals Inc. (INNT)

4.95 +0.28 (+5.996%)

IEX Real-Time Price

August 14, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 4.67

Price Open 4.9

Volume: 496,231

Avg Volume: 853,767

Market Cap: 127.19M

P/E Ratio -

52 Wk Range 3.43-50.5



INNT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
24.38M
1.01M
1.07
4.16%

2018-07-13
24.38M
1.34M
3.64
5.51%

2018-03-15
2.57M
350,427
0.62
13.64%

2018-02-28
1.44M
87,268
2.12
6.08%




News

Midday Gainers / Losers (07/23/2018) (2018-07-23 12:40 SeekingAlpha)

Gainers: DDE +52% . RETA +43% . OASM +38% . LPNT +35% . OTCPK:OMNT +24% . CUR +21% . HCLP +21% . AMRH +21% . CHFS +17% . AWSM +15% . More news on: Dover Downs Gaming & Entertainment, Inc., Reata Pharmaceuticals, Oasmia Pharmaceutical, Stocks on theā€¦

 


Statistics

Shares Outstanding: 25.7M

Top 15 Institution Percent: 3.00

Price To Sales: 187.28

Price To Book: 17.78

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -237.04

Return On Equity: -475.22

Profit Margin: N/A

Price History

Beta: -15.82

50-day Moving Avg: 12.00

200-day Moving Avg: 11.90

YTD Change: -21.50

5-day Change: 2.86

1-month Change: -80.30

3-month Change: -69.68

6-month Change: 26.56

1-year Change: -18.07

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Innovate Biopharmaceuticals Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.innovatebiopharma.com

Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for autoimmune/ inflammatory disease.